Increased serum interleukin 23 in patients with systemic sclerosis
- PMID: 18085738
Increased serum interleukin 23 in patients with systemic sclerosis
Abstract
Objective: The relationship between systemic sclerosis (SSc) and interleukin 23 (IL-23), a cytokine associated with the differentiation of T lymphocytes, is unknown. We investigated serum IL-23 levels and their clinical association in patients with SSc.
Methods: Serum IL-23 levels were examined by ELISA in 63 patients with SSc, 15 patients with systemic lupus erythematosus (SLE), and 31 healthy individuals. SSc patients comprised 25 with limited cutaneous SSc and 38 with diffuse cutaneous SSc.
Results: Serum IL-23 levels were significantly elevated in SSc patients compared to patients with SLE (p < 0.05) and controls (p < 0.005). Elevated serum IL-23 levels were associated with the disease duration (p < 0.05) and the prevalence of pulmonary fibrosis (p < 0.05), although they were not associated with other clinical features, including the extent of skin sclerosis or the severity of pulmonary fibrosis.
Conclusion: The results suggest that IL-23 is associated with induction of SSc and that blockade of IL-23 can be a potential therapeutic strategy in early SSc.
Similar articles
-
Elevated circulating TWEAK levels in systemic sclerosis: association with lower frequency of pulmonary fibrosis.J Rheumatol. 2009 Aug;36(8):1657-62. doi: 10.3899/jrheum.081310. Epub 2009 Jun 16. J Rheumatol. 2009. PMID: 19531747
-
Clinical significance of soluble CD31 in patients with systemic sclerosis (SSc): association with limited cutaneous SSc.J Rheumatol. 2001 Nov;28(11):2460-5. J Rheumatol. 2001. PMID: 11708419
-
Serum interleukin 9 levels are increased in patients with systemic sclerosis: association with lower frequency and severity of pulmonary fibrosis.J Rheumatol. 2011 Oct;38(10):2193-7. doi: 10.3899/jrheum.110268. Epub 2011 Aug 1. J Rheumatol. 2011. PMID: 21807780
-
Juvenile systemic sclerosis: report of three cases and review of Japanese published work.J Dermatol. 2007 Sep;34(9):658-61. doi: 10.1111/j.1346-8138.2007.00350.x. J Dermatol. 2007. PMID: 17727371 Review.
-
A study of the prevalence of systemic sclerosis in northeast England.Rheumatology (Oxford). 2004 May;43(5):596-602. doi: 10.1093/rheumatology/keh124. Epub 2004 Feb 10. Rheumatology (Oxford). 2004. PMID: 14872101 Review.
Cited by
-
CXCL4-RNA Complexes Circulate in Systemic Sclerosis and Amplify Inflammatory/Pro-Fibrotic Responses by Myeloid Dendritic Cells.Int J Mol Sci. 2022 Dec 30;24(1):653. doi: 10.3390/ijms24010653. Int J Mol Sci. 2022. PMID: 36614095 Free PMC article.
-
Theoretical Studies of DNA Microarray Present Potential Molecular and Cellular Interconnectivity of Signaling Pathways in Immune System Dysregulation.Genes (Basel). 2024 Mar 22;15(4):393. doi: 10.3390/genes15040393. Genes (Basel). 2024. PMID: 38674328 Free PMC article.
-
Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations.Arthritis Res Ther. 2009;11(5):R147. doi: 10.1186/ar2821. Epub 2009 Oct 2. Arthritis Res Ther. 2009. PMID: 19799786 Free PMC article.
-
A Mechanistic Insight into the Pathogenic Role of Interleukin 17A in Systemic Autoimmune Diseases.Mediators Inflamm. 2022 May 17;2022:6600264. doi: 10.1155/2022/6600264. eCollection 2022. Mediators Inflamm. 2022. PMID: 35620115 Free PMC article. Review.
-
The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes.PLoS One. 2009 Jun 17;4(6):e5903. doi: 10.1371/journal.pone.0005903. PLoS One. 2009. PMID: 19536281 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical